Beacon Trust’s Biogen BIIB Stock Holding History

Beacon Trust’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	$328K	Buy	1,135 +6	+0.5%	+$1.7K	0.05%	148
2016 Q4	$320K	Sell	1,129 -8	-0.7%	-$2.37K	0.05%	149
2016 Q3	$356K	Buy	1,137 +86	+8%	+$25.5K	0.06%	144
2016 Q2	$254K	Sell	1,051 -3	-0.3%	-$791	0.04%	159
2016 Q1	$274K	Buy	1,054 +200	+23%	+$52.8K	0.05%	151
2015 Q4	$262K	Sell	854 -192	-18%	-$55.2K	0.05%	155
2015 Q3	$305K	Hold	1,046	–	–	0.05%	148
2015 Q2	$423K	Buy	1,046 +50	+5%	+$20.1K	0.07%	135
2015 Q1	$421K	Buy	996 +143	+17%	+$56.4K	0.06%	148
2014 Q4	$290K	Buy	853 +27	+3%	+$8.73K	0.04%	177
2014 Q3	$273K	Sell	826 -8	-1%	-$2.64K	0.05%	165
2014 Q2	$263K	Hold	834	–	–	0.04%	160
2014 Q1	$255K	Buy	+834	New	+$265K	0.04%	155

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Beacon Trust's BIIB Position: Q1 2017 in Review

Beacon Trust increased its Biogen (BIIB) stake by 0.53% in Q1 2017, buying an estimated $1.7K and bringing the position to 1,135 shares worth $328K. The position accounts for 0.05% of the portfolio, ranked #148.

Beacon Trust first reported a position in BIIB in Q1 2014 and has held it in 13 quarters since. The position peaked at $423K in Q2 2015. 1,019 funds tracked by Wall St. Rank hold BIIB as of Q1 2017.

Beacon Trust held 1,135 shares of Biogen worth $328K as of Q1 2017.
Beacon Trust bought 6 Biogen shares in Q1 2017, an estimated $1.7K.
Biogen made up 0.05% of Beacon Trust's portfolio in Q1 2017, its #148 holding.
Beacon Trust first reported a position in Biogen in Q1 2014 and has held it in 13 quarters since.
Beacon Trust's Biogen position peaked at $423K in Q2 2015.
1,019 funds tracked by Wall St. Rank held Biogen as of Q1 2017.

Based on Beacon Trust's 13F filing for Q1 2017, filed 9 May 2017.